Zydus Lifesciences: The company has clarified the recent US court ruling regarding the validity of the patent in Myrbetriq case. He said he was assessing the potential impact of the order and confirmed that negotiations are ongoing as the issue relates to patent-related issues. The company attributes the decline in stock to a Delaware court decision.
Lupin: The company confirmed that a US court has issued an order regarding the Myrbetriq patent case. Lupine has made it clear that it is unaware of information that has not been disclosed to the stock exchange. We are in the process of notifying the exchange of court orders within the required timeline. We are currently assessing the impact of your order and will be provided with an update on the exchange once your assessment is complete.
One 97 communication: Managing Director and Chief Executive Officer Vijay Shekhar Sharma has announced that he has voluntarily abandoned his assigned 2.1 krull ESOP. The result will be a one-time acceleration of ESOP expenses, worth Rs 492 in the fourth quarter of fiscal year 2025.
Gensol Engineering: The company has granted the interim order from Sebi and confirmed its compliance with the directive. Anmol Singh Jaggi and Puneet Singh Jaggi have resigned from the role of Gensol’s management as directed by Sebi.
Ultratech Cement: The company has signed an agreement to acquire a 26% stake in Ampin C&I Power Eight Pvt. For Rs 25.5, aiming to meet green energy requirements and optimize energy costs.
DLF: The company has signed a Master Framework Agreement with Srijan Realty and is selling Kolkata IT/ITES SEZ LAND for Rs 693.
360 wams: The company will preferentially evaluate funding proposals through the issuance of shares and/or warrants.
Glenmark’s Pharmaceuticals: The company plans to release Dextroamphethetamine-Amphetamine tablets, comparable to Adderall, which began distribution in May 2025. IQVIA sales data show that the Adderall tablet market reached approximately $421.7 million in annual revenue in February 2025.
Deepak Nitrite: Deepak Chem Tech, a subsidiary, issued redemptive preferred shares of Rs 100 at a par value of Rs 100 each, allotted them to Deepak Phenolics.
Bharat Heavy Electricals: The company has signed a technology transfer agreement with the Bhabha Atomic Research Center for electrochemical cell separator applications.
Metropolis Healthcare: The company announced that the acquisition of Ashok Kumar Sharma’s scientific pathology is expected to end within 45 days of initially signing a securities subscription share holder agreement.
sml isuzu: Nishikawa Yasushi will be joining the company as managing director and chief executive officer.
AWL Agri Business: The company has acquired an 80% stake in GD Foods Manufacturing (India) Pvt.
Reliance Industrial Infrastructure: The company’s board of directors recommends a dividend of Rs 3.5 per share.
Tanra Platform: The company works with two international communications providers to implement messaging as a rich platform for media communications.
Home First Finance Co: The company has successfully raised Rs 1,250 through the placement of qualified institutions.
Muthoot Capital Services: The company plans to consider a proposal to raise funds through bonds on April 22nd.
MSTC: The company receives income tax demand of Rs 178.4, including Rs 27.9, which includes Rs 27.9, which is rated in 2025.
Bajaj Electricals: The company has announced a partnership with Seak Sro, a Slovakia-based leader in smart lighting and EV charging control systems. According to the CEO, the collaboration represents a significant advance in the company’s efforts to revolutionize tunnel lighting in India.
Petronet LNG: The company has approved the appointment of Saurav Mitra as CFO, effective from April 18th.
SBI Card and Payment Services: The company has partnered with Tata Digital to introduce the Tata Neu SBI card.
Coforge: Company’s Australian arms, A subsidiary of Coforge Tech Australia has acquired 100% of its stake in TMLABS Pty.
Laxmi Dental: The company plans to acquire up to $1 million worth of stake in its foreign subsidiary, Laxmi Dental Lab USA Inc, to determine the terms of its strategic investment. The approvals required for fund transfers are protected from RBI.
Delta Corp: Corporate bonds on the peninsula land have been converted to stocks.
